Carey Moseley

VP Of Payor Relations at Bako Diagnostics

Carey Moseley has extensive experience in the healthcare industry, specializing in payor relations and health plans. Carey currently holds the position of VP of Payor Relations at Bako Diagnostics.

Carey'sprevious roles include Vice President Health Plans, Commercial at Progenity, Inc., where they focused on scaling contracting processes and rebuilding payor relationships. Carey achieved significant wins, such as increasing national payor deals by 10% in revenue and recalibrating process, revenue, and strategy focus as a member of the Responsibility Centered Management Team.

Prior to that, Carey served as the Senior Director of Health Plans, Commercial and National Director, Health Plans at Progenity, where they successfully completed payor contracts, renegotiated rates, and led operations initiatives.

Carey also held positions at Quest Diagnostics, including Health Plan & Payor Market National Director, Health Plan and Payor Markets Strategic Account Executive, and Health Plan & Payor Market AE. In these roles, Carey spearheaded various aspects of payor interaction, including communication, contract negotiation, relationship management, and business review.

Before joining Quest Diagnostics, they worked at LabOne as the Director of Lab Card.

Throughout their career, Carey has consistently demonstrated their expertise in payor relations and health plans, achieving notable accomplishments and earning recognition for their achievements.

Carey Moseley has earned a Bachelor of Science degree in Journalism and Mass Communication from Kansas State University. Their field of study during their education focused on Public Relations, with a minor in History. No specific start or end years are provided for their education at this institution.

Location

Dallas, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Bako Diagnostics

Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako’s comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako’s in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession’s principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.